Rallybio
RLYB
57 hedge funds and large institutions have $212M invested in Rallybio in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 5 closing their positions.
170% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 10
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
8% more funds holding
Funds holding: 53 → 57 (+4)
0.09% more ownership
Funds ownership: 10.81% → 10.91% (+0.09%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
47% less capital invested
Capital invested by funds: $402M → $212M (-$190M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$12.3M |
| 2 |
NLVP
New Leaf Venture Partners
New York
|
+$7.38M |
| 3 |
CA
CHI Advisors
New York
|
+$3.92M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$2.85M |
| 5 |
LCM
Laurion Capital Management
New York
|
+$2.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPX
Canaan Partners XI
Menlo Park,
California
|
-$2.58M |
| 2 |
BlackRock
New York
|
-$271K |
| 3 |
AA
ALPS Advisors
Denver,
Colorado
|
-$254K |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$102K |
| 5 |
Goldman Sachs
New York
|
-$93.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| $7K | -$15.6K | -264 | -66% |
|
52
Allspring Global Investments
Charlotte,
North Carolina
| $6.61K | -$177 | -3 | -2% |
|
53
Citigroup
New York
| $4.27K | -$767 | -13 | -14% |
|
|
RMC
54
Resources Management Corp
West Hartford,
Connecticut
| $2K | – | – | – |
|
55
Wells Fargo
San Francisco,
California
| $1.97K | -$1.65K | -28 | -42% |
|
56
Dimensional Fund Advisors
Austin,
Texas
| $254 | +$114K | +1,935 | +67% |
|
|
CS
57
Credit Suisse
Zurich,
Switzerland
| $7 | -$649 | -11 | Closed |
|
|
AA
58
ALPS Advisors
Denver,
Colorado
| – | -$254K | -2,197 | Closed |
|
|
CUAMC
59
China Universal Asset Management Company
Shanghai,
China
| – | -$4K | -38 | Closed |
|
60
Daiwa Securities Group
Tokyo,
Japan
| – | -$1K | -12 | Closed |
|
61
Nisa Investment Advisors
St. Louis,
Missouri
| – | +$118 | +2 | New |
|
RLYB Hedge Fund Activity: Q4 2022 in Review
57 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q4 2022, worth a combined $212M — down 47% from $402M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new RLYB positions and 5 closed out — a net gain of 5 holders — while 27 added to existing stakes and 10 trimmed.
The largest buyer was Novo Holdings A/S, adding an estimated $12.3M. The largest seller was Canaan Partners XI, cutting an estimated $2.58M.
- 57 institutional investors held Rallybio (RLYB) as of Q4 2022, up from 53 in Q3 2022.
- Funds reported $212M of Rallybio stock for Q4 2022, down 47% quarter-over-quarter.
- 10 funds opened new Rallybio positions in Q4 2022 and 5 closed out, a net change of +5 holders.
- The largest Rallybio buyer in Q4 2022 was Novo Holdings A/S, an estimated $12.3M added.
- The largest Rallybio seller in Q4 2022 was Canaan Partners XI, an estimated $2.58M sold.
Based on aggregated 13F filings for Q4 2022.